AMPK attenuates SHH subgroup medulloblastoma growth and metastasis by inhibiting NF-κB activation
Abstract Background Medulloblastoma (MB) is one of the most common malignant pediatric brain tumors. Metastasis and relapse are the leading causes of death in MB patients. The initiation of the SHH subgroup of MB (SHH-MB) is due to the aberrant activation of Sonic Hedgehog (Shh) signaling. However,...
Main Authors: | Jing Cai, Yue Wang, Xinfa Wang, Zihe Ai, Tianyuan Li, Xiaohong Pu, Xin Yang, Yixing Yao, Junping He, Steven Y. Cheng, Tingting Yu, Chen Liu, Shen Yue |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-01-01
|
Series: | Cell & Bioscience |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13578-023-00963-2 |
Similar Items
-
Clinicopathological Characteristics of non-WNT/non-SHH Medulloblastoma Cases in a Pediatric Egyptian Cohort
by: Soheir M. Hamam, et al.
Published: (2023-02-01) -
Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma Treatment
by: Sutapa Ray, et al.
Published: (2021-12-01) -
Drug Delivery Systems for Hedgehog Inhibitors in the Treatment of SHH-Medulloblastoma
by: Miriam Caimano, et al.
Published: (2021-06-01) -
High expression of DNA methyltransferases in primary human medulloblastoma
by: Tímea Pócza, et al.
Published: (2016-06-01) -
Rare cases of medulloblastoma with hypermutation
by: Aditi Bagchi, et al.
Published: (2022-05-01)